153 related articles for article (PubMed ID: 30497262)
21. Quantitative structure-activity relationship models of clinical pharmacokinetics: clearance and volume of distribution.
Gombar VK; Hall SD
J Chem Inf Model; 2013 Apr; 53(4):948-57. PubMed ID: 23451981
[TBL] [Abstract][Full Text] [Related]
22. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
[TBL] [Abstract][Full Text] [Related]
23. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
Desai PV; Sawada GA; Watson IA; Raub TJ
Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
[TBL] [Abstract][Full Text] [Related]
24. Comparative Analysis of QSAR-based vs. Chemical Similarity Based Predictors of GPCRs Binding Affinity.
Luo M; Wang XS; Tropsha A
Mol Inform; 2016 Jan; 35(1):36-41. PubMed ID: 27491652
[TBL] [Abstract][Full Text] [Related]
25. Quantitative structure-activity relationship models for compounds with anticonvulsant activity.
Bellera CL; Talevi A
Expert Opin Drug Discov; 2019 Jul; 14(7):653-665. PubMed ID: 31072145
[No Abstract] [Full Text] [Related]
26. Matched molecular pair analysis: significance and the impact of experimental uncertainty.
Kramer C; Fuchs JE; Whitebread S; Gedeck P; Liedl KR
J Med Chem; 2014 May; 57(9):3786-802. PubMed ID: 24738976
[TBL] [Abstract][Full Text] [Related]
27. QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α.
Pan J; Zhang Y; Ran T; Xu A; Qiao X; Yin L; Zhou W; Zhu L; Zhao J; Lu T; Chen Y; Jiang Y
Mol Divers; 2017 Aug; 21(3):719-739. PubMed ID: 28689235
[TBL] [Abstract][Full Text] [Related]
28. QSAR analyses of organophosphates for insecticidal activity and its in-silico validation using molecular docking study.
Niraj RR; Saini V; Kumar A
Environ Toxicol Pharmacol; 2015 Nov; 40(3):886-94. PubMed ID: 26492451
[TBL] [Abstract][Full Text] [Related]
29. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
30. Matched Molecular Pair Analysis in Drug Discovery: Methods and Recent Applications.
Yang Z; Shi S; Fu L; Lu A; Hou T; Cao D
J Med Chem; 2023 Apr; 66(7):4361-4377. PubMed ID: 37014039
[TBL] [Abstract][Full Text] [Related]
31. Application of QSAR and shape pharmacophore modeling approaches for targeted chemical library design.
Ebalunode JO; Zheng W; Tropsha A
Methods Mol Biol; 2011; 685():111-33. PubMed ID: 20981521
[TBL] [Abstract][Full Text] [Related]
32. Systematic generation of chemical structures for rational drug design based on QSAR models.
Funatsu K; Miyao T; Arakawa M
Curr Comput Aided Drug Des; 2011 Mar; 7(1):1-9. PubMed ID: 20550510
[TBL] [Abstract][Full Text] [Related]
33. Critically Assessing the Predictive Power of QSAR Models for Human Liver Microsomal Stability.
Liu R; Schyman P; Wallqvist A
J Chem Inf Model; 2015 Aug; 55(8):1566-75. PubMed ID: 26170251
[TBL] [Abstract][Full Text] [Related]
34. MDCKpred: a web-tool to calculate MDCK permeability coefficient of small molecule using membrane-interaction chemical features.
Patel RD; Prasanth Kumar S; Pandya HA; Solanki HA
Toxicol Mech Methods; 2018 Nov; 28(9):685-698. PubMed ID: 29998769
[TBL] [Abstract][Full Text] [Related]
35. Application of predictive QSAR models to database mining: identification and experimental validation of novel anticonvulsant compounds.
Shen M; Béguin C; Golbraikh A; Stables JP; Kohn H; Tropsha A
J Med Chem; 2004 Apr; 47(9):2356-64. PubMed ID: 15084134
[TBL] [Abstract][Full Text] [Related]
36. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
37. A combination of 3D-QSAR modeling and molecular docking approach for the discovery of potential HIF prolyl hydroxylase inhibitors.
Teli MK; Krishnamurthy RG
Med Chem; 2013 May; 9(3):360-70. PubMed ID: 22741796
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
Vyas VK; Gupta N; Ghate M; Patel S
SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of OASIS QSAR Models Using ToxCast™ in Vitro Estrogen and Androgen Receptor Binding Data and Application in an Integrated Endocrine Screening Approach.
Bhhatarai B; Wilson DM; Price PS; Marty S; Parks AK; Carney E
Environ Health Perspect; 2016 Sep; 124(9):1453-61. PubMed ID: 27152837
[TBL] [Abstract][Full Text] [Related]
40. Ecotoxicological QSAR modeling of organic compounds against fish: Application of fragment based descriptors in feature analysis.
Khan K; Baderna D; Cappelli C; Toma C; Lombardo A; Roy K; Benfenati E
Aquat Toxicol; 2019 Jul; 212():162-174. PubMed ID: 31128417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
